📊 Score Breakdown
Offering Ability
60
Cash Runway
40
Float Risk
7
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
25%
📉 Score Deterioration
40%
• Score rose 30 points recently (worsening)
💰 Capital Raise
18%
• Active ATM program with $150M remaining capacity
💹 Market Data
Market Cap$616.35M
Shares Outstanding163.05M
Float142.90M
Cash$116.64M
Debt$26.45M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 8.1% shares (2025Q4 vs prior)
95 institutional holders · 81.95M shares
#1
T. Rowe Price Investment Management, Inc.
13.86M shares
#2
Bain Capital Life Sciences Investors, LLC
9.68M shares
#3
JENNISON ASSOCIATES LLC
8.91M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest22.84M
Days to Cover3.2
% of Float16.0%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2018
8-K
8K EVENT
May 04, 2026
424B5
ATM
May 04, 2026
4
INSIDER TRANSACTION
Mar 02, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CABA
📊 CABA FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CABA Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.